関連する実験動画
Updated: May 5, 2026

08:09
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
9.2K
VE-カデリン/ベータ-カテニンの発現障害は,拡張性心筋疾患における内皮細胞変性を媒介する
Romana Schäfer1, Dietmar Abraham, Patrick Paulus
1Laboratory for Cardiovascular Research, Department of Anatomy, University of Vienna, Vienna, Austria.
Circulation
|September 10, 2003
まとめ
拡張性心筋症 (DCM) では,VEGFから独立して減少したVE-cadherin/β-cateninにより,内皮細胞生存率が低下します. VE-カデリンをターゲットにすることで,DCMに関連するEC病理を治療することができます.
科学分野:
- 心血管生物学 心血管生物学
- 細胞生物学 細胞生物学
- 分子医学は分子医学である.
背景:
- 血管内皮成長因子 (VEGF) -A,アンジオポエチン (Ang),およびVE-カデリン相互作用は,内皮細胞 (EC) の生存を調節する.
- 心臓のVEGF-A発現は拡張性心筋病変 (DCM) で減少しますが,VE-cadherin/Ang信号伝達の役割は不明です.
研究 の 目的:
- DCM患者の心筋内におけるVE-cadherin/β-cateninおよびangiopoietinシグナル伝達の機能を調査する.
- DCMにおけるVE-cadherin/β-catenin,アンジオポエチン,および内皮細胞変性との関係を決定する.
主な方法:
- DCM,発血性心筋症 (ICM),およびリアルタイムRT-PCR,ウエスタン・ブロッティング,および免疫細胞化学を用いた対照被験者におけるVE-カデリン/ベータ-カタニン,Ang-1,Ang-2,およびTie-2の心筋表情を調べた.
- 伝送電子顕微鏡 (TEM) による定量化された内皮細胞変性.
- 培養細胞におけるRNA干渉とVEGF操作を利用して,分子相互作用を探求した.
主要な成果:
- VE-cadherin/β-cateninの発現は,DCMでは著しくダウンレギュレーションされたが,ICMではそうではなかった.
- Ang-2発現はDCMとICMの両方でダウンレギュレーションされ,Tie-2タンパク質はアップレギュレーションされた.
- DCMではICMと比較して内皮細胞の変性率が高く,VE-cadherin遺伝子の静止はDCMに関連するEC病理を模倣した.
結論:
- DCMでは内皮細胞生存が低下し,VE-cadherin/β-catenin機能不全に関連しており,おそらくVEGFから独立している.
- VE-カデリンをターゲットにすることは,DCMに関連した内皮細胞病理学の潜在的な治療戦略です.
関連する概念動画
Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Structure of Cadherins
4.0K
The cadherins were one of the first cell adhesion molecules discovered; the term “cadherins” is based on their calcium-dependent adhering properties. The first cadherins discovered on the epithelial, neuronal, and placental cells were named E-cadherin, P-cadherin, and N-cadherin, respectively. These classical cadherins share sequence and structural similarities. Other cadherins, including those involved in cell signaling, are grouped into non-classical cadherins. This...
4.0K
Catenins
2.2K
Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
2.2K
Cadherins in Tissue Organization
3.5K
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Cell Sorting During Development
Cell sorting plays an...
3.5K
Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805

